Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma

International Journal of Experimental Pathology

Volumn 91, Issue 4, 2010, Pages 357-367

  Mavanur, Arun A ^a   Parimi, Vamsi ^a   O'Malley, Mark ^a   Nikiforova, Marina ^b   Bartlett, David L ^a   Davison, Jon M ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

adenocarcinoma; appendix; loss of heterozygosity; mouse model; pseudomyxoma peritonei; xenograft

Indexed keywords

CYTOKERATIN; KI 67 ANTIGEN; MUCIN; PROTEIN P53; TRANSCRIPTION FACTOR CDX2;

ADENOCARCINOMA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APPENDICEAL MUCINOUS ADENOCARCINOMA; ARTICLE; CANCER SURGERY; CHROMOSOME 10P; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; XENOGRAFT;

ADENOCARCINOMA, MUCINOUS; ANIMALS; APPENDICEAL NEOPLASMS; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 10; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; KERATINS; KI-67 ANTIGEN; LOSS OF HETEROZYGOSITY; MICE; MICE, NUDE; MUCINS; MUTATION; PERITONEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TIME FACTORS; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955068021     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00721.x     Document Type: Article

References (30)

1. Baas I.O., Mulder J.W., Offerhaus G.J., Vogelstein B., Hamilton S.R. (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol. 172, 5 12.
2. Baratti D., Kusamura S., Nonaka D. et al. (2008) Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann. Surg. Oncol. 15, 526 534.
3. Bradley R.F., Stewart J.H.t., Russell G.B., Levine E.A., Geisinger K.R. (2006) Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am. J. Surg. Pathol. 30, 551 559.
4. Carr N.J. Sobin L.H. (1996) Unusual tumors of the appendix and pseudomyxoma peritonei. Semin. Diagn. Pathol. 13, 314 325.
5. Clausen O.P., Lothe R.A., Borresen-Dale A.L. et al. (1998) Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas. Diagn. Mol. Pathol. 7, 215 223.
6. Esrig D., Spruck C.H. III., Nichols P.W. et al. (1993) p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol. 143, 1389 1397.
7. Flatmark K., Reed W., Halvorsen T. et al. (2007) Pseudomyxoma peritonei - two novel orthotopic mouse models portray the PMCA-I histopathologic subtype. BMC Cancer 7, 116.
8. Hahn S.A., Seymour A.B., Hoque A.T. et al. (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res. 55, 4670 4675.
9. Marsh J.W., Finkelstein S.D., Demetris A.J. et al. (2003) Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl. 9, 664 671.
10. McQueen H.A., Wyllie A.H., Piris J., Foster E., Bird C.C. (1991) Stability of critical genetic lesions in human colorectal carcinoma xenografts. Br. J. Cancer 63, 94 96.
11. Miner T.J., Shia J., Jaques D.P., Klimstra D.S., Brennan M.F., Coit D.G. (2005) Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann. Surg. 241, 300 308.
12. Misdraji J., Yantiss R.K., Graeme-Cook F.M., Balis U.J., Young R.H. (2003) Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am. J. Surg. Pathol. 27, 1089 1103.
13. Mukherjee A., Parvaiz A., Cecil T.D., Moran B.J. (2004) Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur. J. Gynaecol. Oncol. 25, 411 414.
14. Nonaka D., Kusamura S., Baratti D., Casali P., Younan R., Deraco M. (2006) CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases Histopathology 49, 381 387.
15. Ohue M., Tomita N., Monden T. et al. (1994) A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res. 54, 4798 4804.
16. Pai R.K., Beck A.H., Norton J.A., Longacre T.A. (2009) Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am. J. Surg. Pathol. 33, 1425 1439.
17. Ronnett B.M., Kurman R.J., Zahn C.M. et al. (1995a) Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum. Pathol. 26, 509 524.
18. Ronnett B.M., Zahn C.M., Kurman R.J., Kass M.E., Sugarbaker P.H., Shmookler B.M. (1995b) Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am. J. Surg. Pathol. 19, 1390 1408.
19. Ronnett B.M., Shmookler B.M., Diener-West M., Sugarbaker P.H., Kurman R.J. (1997) Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int. J. Gynecol. Pathol. 16, 1 9.
20. Ronnett B.M., Yan H., Kurman R.J., Shmookler B.M., Wu L., Sugarbaker P.H. (2001) Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 92, 85 91.
21. Smeenk R.M., Verwaal V.J., Antonini N., Zoetmulder F.A. (2007) Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann. Surg. 245, 104 109.
22. Smeenk R.M., Bruin S.C., van Velthuysen M.L., Verwaal V.J. (2008) Pseudomyxoma peritonei. Curr. Probl. Surg. 45, 527 575.
23. Stewart J.H.T., Shen P., Russell G.B. et al. (2006) Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann. Surg. Oncol. 13, 624 634.
24. Sugarbaker P.H. (2006) The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms. Eur. J. Surg. Oncol. 32, 644 647.
25. Sugarbaker P.H. Jablonski K.A. (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann. Surg. 221, 124 132.
26. Szych C., Staebler A., Connolly D.C., Wu R., Cho K.R., Ronnett B.M. (1999) Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am. J. Pathol. 154, 1849 1855.
27. Yajima N., Wada R., Yamagishi S., Mizukami H., Itabashi C., Yagihashi S. (2005) Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix. Hum. Pathol. 36, 1217 1225.
28. Yoon S.O., Kim B.H., Lee H.S. et al. (2009) Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: a special reference to classification and predictive factors. Mod. Pathol. 22, 1102 1112.
29. Young R.H., Gilks C.B., Scully R.E. (1991) Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am. J. Surg. Pathol. 15, 415 429.
30. Yousem S.A., Nikiforova M., Nikiforov Y. (2008) The histopathology of BRAF-V600E-mutated lung adenocarcinoma. Am. J. Surg. Pathol. 32, 1317 1321.